Abstract:Low zinc bioavailability triggers inflammatory signaling through chronic activation of astrocytes via the PAFR. Active astrocytes release ROS, metabolites, and cytokines that affect synapse formation in developing neurons. Adequate zinc status prevents astrocyte (over)activation. PAFR, platelet activation factor receptor. Astrocytes are important regulators of neuronal development and activity. Their activation plays a key role in the response to many central nervous system (CNS) pathologies. However, reactive astrocytes are a double‐edged sword as their chronic or excessive activation may negatively impact CNS physiology, for example, via abnormal modulation of synaptogenesis and synapse function. Accordingly, astrocyte activation has been linked to neurodegenerative and neurodevelopmental disorders. Therefore, the attenuation of astrocyte activation may be an important approach for preventing and treating these disorders. Since zinc deficiency has been consistently linked to increased pro‐inflammatory signaling, we aimed to identify cellular zinc‐dependent signaling pathways that may lead to astrocyte activation using techniques such as immunocytochemistry and protein biochemistry to detect astrocyte GFAP expression, fluorescent imaging to detect oxidative stress levels in activated astrocytes, cytokine profiling, and analysis of primary neurons subjected to astrocyte secretomes. Our results reveal a so far not well‐described pathway in astrocytes, the platelet activation factor receptor (PAFR) pathway, as a critical zinc‐dependent signaling pathway that is sufficient to control astrocyte reactivity. Low zinc levels activate PAFR signaling‐driven crosstalk between astrocytes and neurons, which alters excitatory synapse formation during development in a PAFR‐dependent manner. We conclude that zinc is a crucial signaling ion involved in astrocyte activation and an important dietary factor that controls astrocytic pro‐inflammatory processes. Thus, targeting zinc homeostasis may be an important approach in several neuroinflammatory conditions.

Zinc Signaling in the Hippocampus and Its Relation to Pathogenesis of Depression

Neuroimmunological aspects of the alterations in zinc homeostasis in the pathophysiology and treatment of depression

Behavioral Abnormality Induced by Enhanced Hypothalamo-Pituitary-Adrenocortical Axis Activity under Dietary Zinc Deficiency and Its Usefulness as a Model

Upregulation of HDAC9 in Hippocampal Neurons Mediates Depression-Like Behaviours by Inhibiting ANXA2 Degradation

Psychological Stress Induced Hippocampus Zinc Dyshomeostasis and Depression-Like Behavior in Rats

Zinc Modulates Hippocampus CA1 Neurons Excitability and Glutamatergic Synaptic Transmission

Zinc and imipramine reverse the depression-like behavior in mice induced by chronic restraint stress

Zinc Deficiency Reduces Neurogenesis Accompanied by Neuronal Apoptosis Through Caspase-Dependent and -Independent Signaling Pathways

Zinc and Central Nervous System Disorders

The Role of Zinc in Mood Disorders

Zinc inhibited LPS-induced inflammatory responses by upregulating A20 expression in microglia BV2 cells

Attenuation of abnormal glutamate release in zinc deficiency by zinc and Yokukansan

Chronic Zinc Exposure Decreases the Surface Expression of NR2A-Containing NMDA Receptors in Cultured Hippocampal Neurons

Polarization to M1-type microglia in the hippocampus is involved in depression-like behavior in a mouse model of olfactory dysfunction

Zinc signaling controls astrocyte‐dependent synapse modulation via the PAF receptor pathway

Effect of Zinc Deficiency on the Formation of Hippocampal Long Term Potentiation

Zinc Ion As Modulator Effects on Excitability and Synaptic Transmission in Hippocampal CA1 Neurons in Wistar Rats

Zinc in Cognitive Impairment and Aging

Hypozincemia in depression

GPR39 (Zinc Receptor) Knockout Mice Exhibit Depression-Like Behavior and CREB/BDNF Down-Regulation in the Hippocampus

Disruption of Brain Zinc Homeostasis Promotes the Pathophysiological Progress of Alzheimer's Disease.